A technique developed by University of Texas at Dallas and UT Southwestern Medical Center researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, the most common human brain cancer. Glioblastoma is an aggressive brain cancer that affects about 12,000 people annually in the U.S.; patients have a median survival of 15 to 18 months after diagnosis. It’s amazing; it’s only a micron thick, but it prevents 98% of molecules from getting inside the brain,” Qin said. UTD researchers involved in the study included Xiaoqin Li PhD’22; Hanwen Fan, mechanical engineering doctoral student; Ryan Margolis, biomedical engineering doctoral student; and Dr. Xiaoqian Ge, mechanical engineering research associate. Dr. Qi Cai, former UTD research associate and now assistant professor of bioengineering at Louisiana State University, was the first author.